Relation of Serum Total Cholesterol and Other Risk Factors to Risk of Coronary Events in Middle-Aged and Elderly Japanese Men With Hypercholesterolemia : The Kyushu Lipid Intervention Study
スポンサーリンク
概要
- 論文の詳細を見る
Background The role of serum total cholesterol (TC) in the development of coronary heart disease (CHD) may differ in different age groups. Methods and Results The relation of serum TC and other risk factors to CHD events was examined in middle-aged (<65 years) and elderly (≥65 years) men separately in the Kyushu Lipid Intervention Study (KLIS). Subjects were 4,349 men aged 45-74 years with serum TC of 220 mg/dl or greater who had no history of myocardial infarction, coronary angioplasty, or stroke. There were 123 CHD events (ie, myocardial infarction, coronary bypass surgery, coronary angioplasty, cardiac death, and sudden death) in a 5-year follow-up period. The Cox proportional hazards model was used with baseline and follow-up serum TC, baseline high-density lipoprotein (HDL) cholesterol, hypertension, diabetes mellitus, and other factors as covariates. Serum TC concentration during the follow-up, not at baseline, was associated with an increased risk of CHD events, especially in elderly men. High concentrations of serum HDL cholesterol were associated with a modest, statistically nonsignificant decrease in the risk among middle-aged men. An increased risk of CHD events associated with diabetes mellitus was greater in middle-aged men. Hypertension and smoking were not measurably related to the risk in either middle-aged or elderly men. Conclusions Both the serum TC concentration during follow-up and diabetes mellitus are important predictors of CHD events in Japanese men with moderately elevated serum TC.
- 社団法人日本循環器学会の論文
- 2004-04-20
著者
-
Kono Suminori
Department Of Preventive Medicine Kyushu University Faculty Of Medical Sciences
-
Kono Suminori
Kyushu University Faculty of Medical Sciences
-
SASAKI Jun
Graduate School of Clinical Trial Management, International University of Health and Welfare
-
IWASHITA Mikio
Department of Preventive Medicine, Kyushu University Faculty of Medical Sciences
-
Iwashita Mikio
Kyushu Lipid Intervention Study (KLIS) Group
-
Matsushita Yasuyuki
Kyushu Lipid Intervention Study (KLIS) Group
-
Sasaki Jun
Kyushu Lipid Intervention Study (KLIS) Group
-
Arakawa Kikuo
Kyushu Lipid Intervention Study (KLIS) Group
-
Iwashita Mikio
Department Of Preventive Medicine Kyushu University Faculty Of Medical Sciences
-
Arakawa Kikuo
Kyushu Lipid Intervention Study (klis) Group:the Second Department Of Internal Medicine Fukuoka Univ
-
Sasaki Jun
Graduate School Of Clinical Trial Management International University Of Health And Welfare
-
Matsushita Yasuyuki
Kyushu Lipid Intervention Study (klis) Group:departments Of Postmarketing Surveillance And Regulator
関連論文
- Gender difference in coronary events in relation to risk factors in Japanese hypercholesterolemic patients treated with low-dose simvastatin
- Statins : Beneficial or Adverse for Glucose Metabolism
- Relation of Serum Total Cholesterol and Other Factors to Risk of Cerebral Infarction in Japanese Men With Hypercholesterolemia : The Kyushu Lipid Intervention Study
- Relation of Serum Total Cholesterol and Other Risk Factors to Risk of Coronary Events in Middle-Aged and Elderly Japanese Men With Hypercholesterolemia : The Kyushu Lipid Intervention Study
- Reduction in Serum Total Cholesterol and Risks of Coronary Events and Cerebral Infarction in Japanese Men : The Kyushu Lipid Intervention Study
- Is the reno-protective effect of valsartan dose dependent? A comparative study of 80 and 160mg day^
- 3 Cutpoint for Categorical Lower HDL cholesterol Concentration in Metabolic Syndrome(Clinical definition of metabolic syndrome,Controversy 3 (C-3) (H),Special Program,The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- 2 Strategy for Treating Hypercholesterolemia from Japanese Evidence(LDL-cholesterol : How Low Should We Go in Japanese Population?, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- Guidelines for Secondary Prevention of Myocardial Infarction (JCS 2011) : Digest Version
- Compound Heterozygotes for a Novel Mutation, Apo E1 Nagoya (Arg142Ser) and Apo E2 (Arg158Cys), with Severe Type III Hyperlipoproteinemia and Familial Hypercholesterolemia